Tri-iodo-l-thyronine promotes the maturation of human cardiomyocytes-derived from induced pluripotent stem cells

Journal of Molecular and Cellular Cardiology

Volumn 72, Issue , 2014, Pages 296-304

  Yang, Xiulan ^a   Rodriguez, Marita ^b   Pabon, Lil ^a   Fischer, Karin A ^c   Reinecke, Hans ^a   Regnier, Michael ^a,d   Sniadecki, Nathan J ^b,d   Ruohola Baker, Hannele ^c   Murry, Charles E ^a,d  

^a UNIVERSITY OF WASHINGTON   (United States)

^b University of Washington   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d University of Washington   (United States)

Author keywords

Cardiomyocyte maturation; Contractile force; Human induced pluripotent stem cell derived cardiomyocytes (hiPSC CMs); Mitochondria; Tri iodo l thyronine

Indexed keywords

ADENOSINE TRIPHOSPHATASE; LIOTHYRONINE; PROTEIN P21; CALCIUM; CULTURE MEDIUM; CYCLIN DEPENDENT KINASE INHIBITOR 1A; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE;

ANISOTROPY; ARTICLE; CALCIUM TRANSPORT; CELL CULTURE; CELL CYCLE PROGRESSION; CELL MATURATION; CELL PROLIFERATION; CELL SIZE; CELLULAR PARAMETERS; CONTRACTILE KINETICS; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; EXTRACELLULAR CALCIUM; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILE FORCE; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MITOCHONDRIAL GENOME; MITOCHONDRIAL RESPIRATION; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SARCOMERE LENGTH; ANIMAL; CELL CYCLE; CELL DIFFERENTIATION; CULTURE MEDIUM; CYTOLOGY; DRUG EFFECTS; FIBROBLAST; GENE EXPRESSION; GENETICS; LUNG; METABOLISM; MITOCHONDRION; MOUSE; OXIDATIVE PHOSPHORYLATION; PHARMACOLOGY; SARCOMERE;

ANIMALS; CALCIUM; CELL CYCLE; CELL DIFFERENTIATION; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; CYCLIN-DEPENDENT KINASE INHIBITOR P21; FIBROBLASTS; GENE EXPRESSION; HUMANS; INDUCED PLURIPOTENT STEM CELLS; LUNG; MICE; MITOCHONDRIA; MYOCYTES, CARDIAC; OXIDATIVE PHOSPHORYLATION; SARCOMERES; SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES; TRIIODOTHYRONINE;

EID: 84900335420     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2014.04.005     Document Type: Article

References (42)

1. Laflamme M.A., Murry C.E. Heart regeneration. Nature 2011, 473:326-335.
2. Burridge P.W., Keller G., Gold J.D., Wu J.C. Production of de novo cardiomyocytes: human pluripotent stem cell differentiation and direct reprogramming. Cell Stem Cell 2012, 10:16-28.
3. Yang X., Pabon L., Murry C.E. Engineering adolescence: maturation of human pluripotent stem cell-derived cardiomyocytes. Circ Res 2014, 114:511-523.
4. Kruger M., Sachse C., Zimmermann W.H., Eschenhagen T., Klede S., Linke W.A. Thyroid Hormone regulates developmental titin isoform transitions via the phosphatidylinositol-3-kinase/Akt pathway. Circ Res 2008, 102:439-447.
5. Klein I., Ojamaa K. Thyroid hormone and the cardiovascular system. N Engl J Med 2001, 344:501-509.
6. Lahmers S., Wu Y., Call D.R., Labeit S., Granzier H. Developmental control of titin isoform expression and passive stiffness in fetal and neonatal myocardium. Circ Res 2004, 94:505-513.
7. Opitz C.A., Leake M.C., Makarenko I., Benes V., Linke W.A. Developmentally regulated switching of titin size alters myofibrillar stiffness in the perinatal heart. Circ Res 2004, 94:967-975.
8. Warren C.M., Krzesinski P.R., Campbell K.S., Moss R.L., Greaser M.L. Titin isoform changes in rat myocardium during development. Mech Dev 2004, 121:1301-1312.
9. Dillmann W.H. Cellular action of thyroid hormone on the heart. Thyroid 2002, 12:447-452.
10. Breall J.A., Rudolph A.M., Heymann M.A. Role of thyroid hormone in postnatal circulatory and metabolic adjustments. J Clin Invest 1984, 73:1418-1424.
11. Fisher D.A. Fetal thyroid function: diagnosis and management of fetal thyroid disorders. Clin Obstet Gynecol 1997, 40:16-31.
12. Macchia P.E. Recent advances in understanding the molecular basis of primary congenital hypothyroidism. Mol Med Today 2000, 6:36-42.
13. Chattergoon N.N., Giraud G.D., Louey S., Stork P., Fowden A.L., Thornburg K.L. Thyroid hormone drives fetal cardiomyocyte maturation. FASEB J 2012, 26:397-408.
14. Deng X.F., Rokosh D.G., Simpson P.C. Autonomous and growth factor-induced hypertrophy in cultured neonatal mouse cardiac myocytes. Comparison with rat. Circ Res 2000, 87:781-788.
15. Lee Y.K., Ng K.M., Chan Y.C., Lai W.H., Au K.W., Ho C.Y., et al. Triiodothyronine promotes cardiac differentiation and maturation of embryonic stem cells via the classical genomic pathway. Mol Endocrinol 2010, 24:1728-1736.
16. Thorpe-Beeston J.G., Nicolaides K.H., Felton C.V., Butler J., McGregor A.M. Maturation of the secretion of thyroid hormone and thyroid-stimulating hormone in the fetus. N Engl J Med 1991, 324:532-536.
17. Ivashchenko C.Y., Pipes G.C., Lozinskaya I.M., Lin Z., Xiaoping X., Needle S., et al. Human-induced pluripotent stem cell-derived cardiomyocytes exhibit temporal changes in phenotype. Am J Physiol Heart Circ Physiol 2013, 305:H913-H922.
18. Yu J., Vodyanik M.A., Smuga-Otto K., Antosiewicz-Bourget J., Frane J.L., Tian S., et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007, 318:1917-1920.
19. Makarenko I., Opitz C.A., Leake M.C., Neagoe C., Kulke M., Gwathmey J.K., et al. Passive stiffness changes caused by upregulation of compliant titin isoforms in human dilated cardiomyopathy hearts. Circ Res 2004, 95:708-716.
20. Rao M., Li L., Demello C., Guo D., Jaber B.L., Pereira B.J., et al. Mitochondrial DNA injury and mortality in hemodialysis patients. J Am Soc Nephrol 2009, 20:189-196.
21. Tan J.L., Tien J., Pirone D.M., Gray D.S., Bhadriraju K., Chen C.S. Cells lying on a bed of microneedles: an approach to isolate mechanical force. Proc Natl Acad Sci U S A 2003, 100:1484-1489.
22. Sniadecki N.J., Chen C.S. Microfabricated silicone elastomeric post arrays for measuring traction forces of adherent cells. Methods in cell biology: cell mechanics 2007, 313-328. Elsevier Inc., San Diego, CA. Y. Wang, D.E. Discher (Eds.).
23. Rodriguez M.L., Graham B.T., Pabon L.M., Han S.J., Murry C.E., Sniadecki N.J. Measuring the contractile forces of human induced pluripotent stem cell-derived cardiomyocytes with arrays of microposts. J Biomech Eng 2014, 136:510051-5100510.
24. Korte F.S., Dai J., Buckley K., Feest E.R., Adamek N., Geeves M.A., et al. Upregulation of cardiomyocyte ribonucleotide reductase increases intracellular 2 deoxy-Atp, contractility, and relaxation. J Mol Cell Cardiol 2011, 51:894-901.
25. Lundy S.D., Zhu W.Z., Regnier M., Laflamme M.A. Structural and functional maturation of cardiomyocytes derived from human pluripotent stem cells. Stem Cells Dev 2013, 22:1991-2002.
26. Jacot J.G., McCulloch A.D., Omens J.H. Substrate stiffness affects the functional maturation of neonatal rat ventricular myocytes. Biophys J 2008, 95:3479-3487.
27. Rodriguez A.G., Han S.J., Regnier M., Sniadecki N.J. Substrate stiffness increases twitch power of neonatal cardiomyocytes in correlation with changes in myofibril structure and intracellular calcium. Biophys J 2011, 101:2455-2464.
28. Spach M.S., Heidlage J.F., Barr R.C., Dolber P.C. Cell size and communication: role in structural and electrical development and remodeling of the heart. Heart Rhythm 2004, 1:500-515.
29. Heineke J., Molkentin J.D. Regulation of cardiac hypertrophy by intracellular signalling pathways. Nat Rev Mol Cell Biol 2006, 7:589-600.
30. Maillet M., van Berlo J.H., Molkentin J.D. Molecular basis of physiological heart growth: fundamental concepts and new players. Nat Rev Mol Cell Biol 2013, 14:38-48.
31. Kita-Matsuo H., Barcova M., Prigozhina N., Salomonis N., Wei K., Jacot J.G., et al. Lentiviral vectors and protocols for creation of stable hESC lines for fluorescent tracking and drug resistance selection of cardiomyocytes. PLoS One 2009, 4:e5046.
32. Lieu D.K., Liu J., Siu C.W., McNerney G.P., Tse H.F., Abu-Khalil A., et al. Absence of transverse tubules contributes to non-uniform ca(2+) wavefronts in mouse and human embryonic stem cell-derived cardiomyocytes. Stem Cells Dev 2009, 18:1493-1500.
33. Wang I.N., Wang X., Ge X., Anderson J., Ho M., Ashley E., et al. Apelin enhances directed cardiac differentiation of mouse and human embryonic stem cells. PLoS One 2012, 7:e38328.
34. Sun N., Yazawa M., Liu J., Han L., Sanchez-Freire V., Abilez O.J., et al. Patient-specific induced pluripotent stem cells as a model for familial dilated cardiomyopathy. Sci Transl Med 2012, 4:130ra147.
35. Taylor R.E., Kim K., Sun N., Park S.J., Sim J.Y., Fajardo G., et al. Sacrificial layer technique for axial force post assay of immature cardiomyocytes. Biomed Microdevices 2013, 15:171-181.
36. Hill B.G., Dranka B.P., Zou L., Chatham J.C., Darley-Usmar V.M. Importance of the bioenergetic reserve capacity in response to cardiomyocyte stress induced by 4-hydroxynonenal. Biochem J 2009, 424:99-107.
37. Callis T.E., Pandya K., Seok H.Y., Tang R.H., Tatsuguchi M., Huang Z.P., et al. Microrna-208a is a regulator of cardiac hypertrophy and conduction in mice. J Clin Invest 2009, 119:2772-2786.
38. Peters N.S., Severs N.J., Rothery S.M., Lincoln C., Yacoub M.H., Green C.R. Spatiotemporal relation between gap junctions and fascia adherens junctions during postnatal development of human ventricular myocardium. Circulation 1994, 90:713-725.
39. Davis P.J., Lin H.Y., Mousa S.A., Luidens M.K., Hercbergs A.A., Wehling M., et al. Overlapping nongenomic and genomic actions of thyroid hormone and steroids. Steroids 2011, 76:829-833.
40. Cheng S.Y., Leonard J.L., Davis P.J. Molecular aspects of thyroid hormone actions. Endocr Rev 2010, 31:139-170.
41. Blanchet E., Bertrand C., Annicotte J.S., Schlernitzauer A., Pessemesse L., Levin J., et al. Mitochondrial T3 receptor p43 regulates insulin secretion and glucose homeostasis. FASEB J 2012, 26:40-50.
42. Goglia F. Biological effects of 3,5-diiodothyronine (T(2)). Biochemistry (Mosc) 2005, 70:164-172.